AMH and breast cancer: These data indicate that measurement of AMH following chemotherapy for breast cancer using the improved sensitivity of the Roche Diagnostics automated Elecsys® assay is an accurate diagnostic test of menopausal status after recovery from treatment, and that analysis at the end of chemotherapy may predict POI.